A prospective evaluation of VEGF-targeted treatment cessation in metastatic clear cell renal cancer
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A prospective evaluation of VEGF-targeted treatment cessation in metastatic clear cell renal cancer
Authors
Keywords
-
Journal
ANNALS OF ONCOLOGY
Volume 24, Issue 8, Pages 2098-2103
Publisher
Oxford University Press (OUP)
Online
2013-04-12
DOI
10.1093/annonc/mdt130
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Contrasting effects of sunitinib within in vivo models of metastasis
- (2012) Jonathan C. Welti et al. ANGIOGENESIS
- Rapid Angiogenesis Onset after Discontinuation of Sunitinib Treatment of Renal Cell Carcinoma Patients
- (2012) A. W. Griffioen et al. CLINICAL CANCER RESEARCH
- Complete Remission With Tyrosine Kinase Inhibitors in Renal Cell Carcinoma
- (2012) Laurence Albiges et al. JOURNAL OF CLINICAL ONCOLOGY
- Randomized Phase II Trial of Sunitinib on an Intermittent Versus Continuous Dosing Schedule As First-Line Therapy for Advanced Renal Cell Carcinoma
- (2012) Robert J. Motzer et al. JOURNAL OF CLINICAL ONCOLOGY
- Sequential FDG-PET/CT as a Biomarker of Response to Sunitinib in Metastatic Clear Cell Renal Cancer
- (2011) Irfan Kayani et al. CLINICAL CANCER RESEARCH
- The Outcome of Patients Treated with Sunitinib Prior to Planned Nephrectomy in Metastatic Clear Cell Renal Cancer
- (2011) Thomas Powles et al. EUROPEAN UROLOGY
- A Phase II Study of Presurgical Sunitinib in Patients With Metastatic Clear-cell Renal Carcinoma and the Primary Tumor In Situ
- (2011) Axel Bex et al. UROLOGY
- Impact of Cytoreductive Nephrectomy on Eligibility for Systemic Treatment and Effects on Survival: Are Surgical Complications or Disease Related Factors Responsible?
- (2011) Rebecca L. O'Malley et al. UROLOGY
- Outcome of treatment discontinuation in patients with metastatic renal cell carcinoma and no evidence of disease following targeted therapy with or without metastasectomy
- (2010) M. Johannsen et al. ANNALS OF ONCOLOGY
- Pazopanib in Locally Advanced or Metastatic Renal Cell Carcinoma: Results of a Randomized Phase III Trial
- (2010) Cora N. Sternberg et al. JOURNAL OF CLINICAL ONCOLOGY
- The reverse side of the victory: Flare up of symptoms after discontinuation of sunitinib or sorafenib in renal cell cancer patients. A report of three cases
- (2009) Ingrid M. E. Desar et al. ACTA ONCOLOGICA
- Use of systemic therapy and factors affecting survival for patients undergoing cytoreductive nephrectomy
- (2009) Alexander Kutikov et al. BJU INTERNATIONAL
- Accelerated Metastasis after Short-Term Treatment with a Potent Inhibitor of Tumor Angiogenesis
- (2009) John M.L. Ebos et al. CANCER CELL
- Overall Survival and Updated Results for Sunitinib Compared With Interferon Alfa in Patients With Metastatic Renal Cell Carcinoma
- (2009) Robert J. Motzer et al. JOURNAL OF CLINICAL ONCOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started